Drug Shortage Report for INHIBACE PLUS

Last updated on 2022-05-25 History
Report ID 160204
Drug Identification Number 02181479
Brand name INHIBACE PLUS
Common or Proper name INHIBACE PLUS
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CILAZAPRIL
Strength(s) 12.5MG 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 28 tablets
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-09
Estimated end date 2022-08-31
Actual end date 2022-05-24
Shortage status Resolved
Updated date 2022-05-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-05-25 English Compare
v6 2022-05-24 French Compare
v5 2022-05-24 English Compare
v4 2022-05-10 English Compare
v3 2022-05-09 French Compare
v2 2022-05-09 English Compare
v1 2022-05-09 English Compare

Showing 1 to 7 of 7